What Traditional Chinese Medicine Formulations Are Used to Treat Chronic Cholecystitis?

Chronic cholecystitis—a persistent, low-grade inflammation of the gallbladder—often stems from recurrent episodes of acute cholecystitis, typically associated with gallstones, biliary sludge, or functional biliary dyskinesia. While definitive management may involve cholecystectomy in symptomatic or complicated cases, many patients seek adjunctive medical therapies to alleviate symptoms such as right upper quadrant discomfort, bloating, nausea after fatty meals, and intermittent dyspepsia.

In clinical practice within China, certain traditional Chinese medicine (TCM) formulations are commonly prescribed as part of integrative treatment strategies for chronic cholecystitis. Among these, Jin Yin Hua Lian Qiao Tang (a decoction containing honeysuckle flower and forsythia fruit) and Qing Dan Li Shi Tang (“Clear Gallbladder and Resolve Calculi Decoction”) are frequently utilized for their purported hepatobiliary regulatory, anti-inflammatory, and cholagogue effects. Standardized proprietary preparations—including Dan Ling Pian, Qing Kai Ling Injection (used cautiously and only under supervision due to infusion-related risks), and Shu Gan Li Dan Pian—are also employed to support bile flow, reduce hepatic congestion, and modulate inflammatory pathways.

It is critical to emphasize that none of these TCM formulations have received regulatory approval from major international agencies—including the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA)—for the treatment of chronic cholecystitis. Robust, large-scale randomized controlled trials validating their efficacy and safety in this specific indication remain limited. Moreover, potential herb–drug interactions (e.g., with anticoagulants or cytochrome P450–metabolized medications), batch-to-batch variability in active constituents, and risks of adulteration or heavy metal contamination necessitate careful clinical oversight.

Current evidence-based guidelines—including those from the American College of Gastroenterology and the European Association for the Study of the Liver—recommend conservative management with dietary modification (low-fat diet), analgesia, and, when indicated, surgical consultation for cholecystectomy. TCM preparations may be considered only as complementary options within a shared decision-making framework, following thorough patient counseling about evidence limitations and potential risks.